Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 1.000 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.586 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.583 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.562 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.562 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.547 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.531 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.530 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.529 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.528 | |
| 4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.527 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.527 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.526 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.525 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.523 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.518 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.517 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.517 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.517 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.517 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.516 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.516 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.515 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.515 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.515 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.514 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.512 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.512 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.512 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.512 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.510 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.510 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.509 | |
| 1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.507 | |
| 3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.507 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.507 | |
| 4y95 | 746 | Tyrosine-protein kinase | / | 0.506 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.505 | |
| 3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.504 | |
| 4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.504 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.503 | |
| 2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.502 | |
| 3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.502 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.502 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.501 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.500 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.500 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.498 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.498 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.498 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.497 | |
| 2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.497 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.497 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.497 | |
| 4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.497 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.496 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.495 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.494 | |
| 3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.494 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.493 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.493 | |
| 2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.492 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.492 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.491 | |
| 2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.491 | |
| 3cjf | SAV | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.491 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.491 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.491 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.490 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.489 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.488 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.487 | |
| 2ym3 | YM3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.486 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.486 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.485 | |
| 3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.485 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.485 | |
| 4fnz | NZF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.485 | |
| 4dce | 0JF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.484 | |
| 1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.483 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.483 | |
| 4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.483 | |
| 5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.483 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.481 | |
| 2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
| 4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.481 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.481 | |
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
| 2pzr | ACP | Fibroblast growth factor receptor 2 | / | 0.480 | |
| 4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
| 2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.479 | |
| 4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.479 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.479 | |
| 1agw | SU2 | Fibroblast growth factor receptor 1 | / | 0.478 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.478 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.478 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.478 | |
| 3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.478 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.478 | |
| 4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.478 | |
| 4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.477 | |
| 2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.476 | |
| 1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.475 | |
| 2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.475 | |
| 2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.475 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.475 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.474 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.473 | |
| 3tuc | FPW | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.473 | |
| 2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
| 2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.472 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.472 | |
| 2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.472 | |
| 2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.471 | |
| 4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.471 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.471 | |
| 4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
| 2pvy | ACP | Fibroblast growth factor receptor 2 | / | 0.470 | |
| 2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.470 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.470 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.470 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.470 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.470 | |
| 4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.470 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.470 | |
| 1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.469 | |
| 2i1m | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.469 | |
| 2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.469 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.469 | |
| 4ftn | 2HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
| 4riy | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.469 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.468 | |
| 3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.468 | |
| 4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
| 4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
| 2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.466 | |
| 3g0f | B49 | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.466 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.465 | |
| 4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.465 | |
| 4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.465 | |
| 1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.464 | |
| 2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.464 | |
| 3lmg | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.464 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.464 | |
| 4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.464 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.464 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.464 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
| 3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.463 | |
| 3q5i | ANP | Protein kinase, putative | / | 0.463 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.463 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.463 | |
| 2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
| 2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.462 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.462 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.461 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.461 | |
| 4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.461 | |
| 4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.461 | |
| 1uv5 | BRW | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.460 | |
| 2rg5 | 279 | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.460 | |
| 3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.459 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.459 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.458 | |
| 3ag9 | A02 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.458 | |
| 3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.458 | |
| 3acj | KSS | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.457 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.457 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.456 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.456 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.456 | |
| 4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.456 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
| 4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.456 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.456 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.455 | |
| 2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.455 | |
| 3krw | BA1 | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.455 | |
| 4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.455 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.454 | |
| 1di9 | MSQ | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.454 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.454 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.454 | |
| 4fsy | HK7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
| 4gh2 | HK0 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
| 4ng5 | PFB | Alcohol dehydrogenase E chain | 1.1.1.1 | 0.454 | |
| 2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.453 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.453 | |
| 2zm4 | KSM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.453 | |
| 3gb2 | G3B | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.453 | |
| 4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.453 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.452 | |
| 3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 3vo3 | 0KF | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.451 | |
| 4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.451 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.450 | |
| 2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 3ppk | FNI | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.450 | |
| 4d9t | 0JG | Ribosomal protein S6 kinase alpha-3 | 2.7.11.1 | 0.450 | |
| 4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.450 | |
| 1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.449 | |
| 2wmt | ZYT | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 3ocg | OCG | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 1w84 | L12 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.448 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.448 | |
| 3g0e | B49 | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.448 | |
| 3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.448 | |
| 4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.448 | |
| 4dn5 | AGS | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.448 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.448 | |
| 5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.448 | |
| 1mvs | DTM | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.447 | |
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.447 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.447 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
| 2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.446 | |
| 2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
| 2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
| 3eb0 | DRK | Uncharacterized protein | / | 0.446 | |
| 3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.445 | |
| 2g2f | AGS | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.445 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.445 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.445 | |
| 4fta | H5K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.445 | |
| 1h1w | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
| 2acx | ANP | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.444 | |
| 2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.444 | |
| 2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.444 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
| 1x2h | LPA | Lipoate-protein ligase A | 6.3.1.20 | 0.443 | |
| 2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 3e8e | G98 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.443 | |
| 3pvu | QRW | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.443 | |
| 4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.443 | |
| 4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 1pme | SB2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
| 2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
| 2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.442 | |
| 2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2x8e | X8E | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 3zrm | ZRM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
| 4afj | SJJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
| 2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
| 3lij | ANP | Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands | / | 0.441 | |
| 4b7t | CWT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.441 | |
| 4l4c | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
| 2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 2vnh | FAD | NADPH:ferredoxin reductase | / | 0.440 | |
| 2ym8 | YM8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 3b2t | M33 | Fibroblast growth factor receptor 2 | / | 0.440 | |
| 3lct | ADP | ALK tyrosine kinase receptor | 2.7.10.1 | 0.440 | |
| 4h3g | 10Q | Beta-secretase 1 | 3.4.23.46 | 0.440 | |
| 5kj6 | PFB | Alcohol dehydrogenase E chain | 1.1.1.1 | 0.440 |